Literature DB >> 27505080

Hyperfunctioning papillary thyroid carcinoma: A case report with literature review.

Abdulwahid M Salih1, F H Kakamad2, Han Nihad3.   

Abstract

INTRODUCTION: Thyroid malignant tumors are rarely associated with hyperfunctioning thyroid. The incidence of this co-incidence is highly variable. Here we report a rare case of papillary thyroid cancer associated with hyperthyroidism with brief literature review. CASE REPORT: A 40-year-old male, presented with palpitation, excess sweating and weight loss for one month duration. There was asymmetrical swelling of the neck, more on right side, mobile. Free T3: 11.09pmol/L, free T4: 34.41pmol/L, TFT: less than 0.005mIU/ml, Neck ultrasound showed features of background thyroiditis. Left lobe contained 9×7×5mm nodule with irregular outline and multiple dots of calcification, other nodules are of the same features. Under ultrasound guide, fine needle aspiration cytology showed features of papillary carcinoma. After preparation, total thyrodectomy done and the result of histopathological examination confirmed papillary thyroid carcinoma. The patient was put on 0.2mg thyroxine daily. DISCUSSION: Literature review has showed an increasing number of papers reporting the association of high level of thyroid function tests and thyroid malignancy. The cause of high level of TH in thyroid malignancy is thought to be due to an active mutation of the gene of TH receptor. Niepomniszcze and colleagues found that a combination of TSH receptor mutations and Ki-RAS was the main etiological factor for hyperfunction of the thyroid malignancy.
CONCLUSION: Although the coexistence of them is rare, thyroid malignancy should be put in the differential diagnosis of hyperthyroid goiter.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Hyperthyroidism; Ki-RAS; Papillary thyroid carcinoma; Thymoglobulin

Year:  2016        PMID: 27505080      PMCID: PMC4978214          DOI: 10.1016/j.ijscr.2016.08.001

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

According to the literature, thyroid malignant tumors are rarely associated with hyperfunctioning thyroid. The incidence of this co-incidence is highly variable reported to be as low as 0.15% [1]. In daily practice, thyroid mass detected either by physical examination or by ultrasound in an individual with high thyroid function tests is suggestive for a benign condition [2]. Malignant thyroid nodules appear as cold nodules on scintigraphy and they are clinically euthyroid [3]. Hyperthyroidism associated with thyroid carcinoma is a rare presentation [3]. Here we report a rare case of papillary thyroid cancer associated with hyperthyroidism with brief literature review. The work has been reported in line with the CARE criteria [4].

Patient information

A 40-year-old male, Kurdish employee presented with palpitation, excess sweating and weight loss for one month duration with negative past-medical, past-surgical and family history.

Clinical findings

A symmetrical swelling of the neck, more on right side, mobile, non-tender, with negative translumination test. No lymph node enlargement. General and systemic examination were negative for signs of metastasis.

Diagnostic assessment

Complete blood count was normal. Free T3: 11.09 pmol/L, free T4: 34.41 pmol/L, TFT: less than 0.005 mIU/ml, Thymoglobulin was normal. Thyroid antibodies were negative. Neck ultrasound showed features of background thyroiditis. Left lobe contained 9 × 7 × 5 mm nodule with irregular outline and multiple dots of calcification, other nodules (2 in right one in left) are of the same features, largest one in right lobe, of about 28, 32, 21 mm in size. No evidence of lymph node metastasis was seen. Under ultrasound guide, fine needle aspiration was performed for the right and left sides. The results showed follicular epithelium with crowded sheets and micronodular formation, the oval nuclei enlarged with coarse chromatins, nuclear grooves and pseudoepithelium.

Therapeutic intervention

The patient was put on rapid preparation for operation by propranolol (40 mg*3), prednisolone (20 mg*2) and methimazole (15 mg*3) for 2 weeks. Thyroid function tests were normal 2 days before operation. Preoperative intravenous antibiotic (1 g of ceftriaxone) has been given. Under general anesthesia, total thyrodectomy was done. There was neither not lymph node involvement nor infilteration of the surrounding tissue. The result of histopathological examination showed multicentric characteristic oval nuclei with grooving confirming papillary thyroid carcinoma (Fig. 1).
Fig. 1

Papillary carcinoma with the characteristic oval nuclei with grooving (black arrow), multinodular background (white arrow), ground glass appearance (yellow arrow).

Follow-up and outcomes

The patient stayed in hospital for onenight. He was put on 0.2 mg thyroxine daily and submitted to I-131 treatment. Clinical and laboratory examination was normal one month after operation. The result of isostope scan was negative.

Discussion

Patients with hyperthyroidism used to be regarded as having low risk for a thyroid cancer. Literature review has showed an increasing number of papers reporting the association of high level of thyroid function tests and thyroid malignancy [1], [2], [3], [5]. Gabriele et al. showed 7 patients of thyroid cancer among 425 hyperthyroid patients. Five of them were Papillary carcinoma and the other 2 were follicular carcinoma. None of Graves’ patients (15%) had thyroid malignancy [6]. Bałdys et al. reported a young male with graves’ disease and papillary microcarcinoma [7]. Kinkel et al. also published a report of a middle age female with hyperthyroidism and Graves’ diseases. Twelve months after antithyroid medication thyroidectomy was performed to treat recurrence and histopathological examination showed papillary cancer [8]. Al-Omari et al. reported of a 65-years-old male who was diagnosed as case of Graves disease and radioisotope scaning showed diffuse goiter and a cold nodule. Fine needle aspiration suggested malignancy and confirmed by histopathological examination of the specimen after total thyroidectomy [9]. Other 2 studies found 1.1% and 2.1% of thyroid carcinoma associated with high level of thyroid hormone (TH) [10], [11]. Harach and coworkers described the microscopical findings of 73 hot nodules in which carcinoma were observed in 6 patients (8.2%) [12]. According to De Rosa et al. only 18 patients of hyperfunctioning papillary thyroid carcinoma have been reported in last 25 years. They concluded that high functioning goiter does not exclude carcinoma during diagnostic work up of hot nodules [13]. Two articles reported papillary thyroid carcinoma with hyperthyroidism and extensive distant metastasis and their authors contributed the high level of (TH) these 2 patients to bone metastasis [9], [14]. The cause of high level of TH in thyroid malignancy is thought to be due to an active mutation of the gene of TH receptor [15]. Niepomniszcze and colleagues found that a combination of TSH receptor mutations and Ki-RAS was the main etiological factor for hyperfunction of the thyroid malignancy [5]. Although the coexistence of them is rare, thyroid malignancy should be put in the differential diagnosis of Graves’ disease and hyperthyroid goiter. Thorough history and physical examination should be done and necessary investigation should be sent in order not to miss this rare but important association.

Patient perspective

The patient satisfied and was comfortable one month after operation.

Conflict of interest

There is no conflict of interest.

Funding

No source to be stated.

Ethical approval

Approval has been taken from bioscience center.

Consent

Consent has been taken.

Author contribution

Abdulwahid M. Salih: Surgeon performed the operation and follow up. Fahmi H. Kakamad: writing the manuscript and follow up. Han Aube: Examining the specimen, follow up.

Guarantor

Fahmi Hussein Kakamad.
  13 in total

1.  Thyroid cancer in hyperthyroidism: incidence rates and value of ultrasound-guided fine-needle aspiration biopsy in this patient group.

Authors:  M Sahin; N D Guvener; F Ozer; A Sengul; D Ertugrul; N B Tutuncu
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

2.  Carcinoma of the thyroid manifested as hyperthyroidism caused by functional bone metastasis.

Authors:  K Ikejiri; M Furuyama; T Muranaka; H Anai; S Takeo; K Sakai; M Saku; K Yoshida
Journal:  Clin Nucl Med       Date:  1997-04       Impact factor: 7.794

3.  Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma?

Authors:  Hulya Gozu; Melike Avsar; Rifat Bircan; Serap Sahin; Rengin Ahiskanali; Bahadir Gulluoglu; Oguzhan Deyneli; Tunc Ones; Yavuz Narin; Sema Akalin; Beyazit Cirakoglu
Journal:  Thyroid       Date:  2004-11       Impact factor: 6.568

4.  Graves disease and papillary thyroid cancer. An association that can be missed.

Authors:  Ahmad A Al-Omari; Fares H Haddad; Haytham M Khushman; Omar M Malkawi
Journal:  Saudi Med J       Date:  2005-08       Impact factor: 1.484

5.  Thyroid carcinoma mimicking a toxic adenoma.

Authors:  G De Rosa; A Testa; M Maurizi; M A Satta; C Aimoni; A Artuso; E Silvestri; V Rufini; L Troncone
Journal:  Eur J Nucl Med       Date:  1990

6.  [A case of Graves-Basedow disease with orbitopathy and papillary thyroid cancer].

Authors:  Agata Bałdys-Waligórska; Filip Gołkowski; Grzegorz Sokołowski; Monika Buziak-Bereza; Maciej Skalski; Alicja Hubalewska-Dydejczyk
Journal:  Endokrynol Pol       Date:  2008 Nov-Dec       Impact factor: 1.582

7.  The CARE guidelines: consensus-based clinical case report guideline development.

Authors:  Joel J Gagnier; Gunver Kienle; Douglas G Altman; David Moher; Harold Sox; David Riley
Journal:  J Clin Epidemiol       Date:  2013-09-12       Impact factor: 6.437

8.  [Thyroid cancer in patients with Grave's Disease].

Authors:  R Mssrouri; S Benamr; A Essadel; J Mdaghri; El H Mohammadine; M-K Lahlou; A Taghy; A Belmahi; B Chad
Journal:  J Chir (Paris)       Date:  2008 May-Jun

9.  Severe hyperthyroidism due to metastatic papillary thyroid carcinoma with favorable outcome.

Authors:  M E Girelli; D Casara; D Rubello; M R Pelizzo; B Busnardo; D Ziliotto
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

10.  Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.

Authors:  Won Bae Kim; Seong-Min Han; Tae Yong Kim; Il Seong Nam-Goong; Gyungyub Gong; Ho Kyu Lee; Suck Joon Hong; Young Kee Shong
Journal:  Clin Endocrinol (Oxf)       Date:  2004-06       Impact factor: 3.478

View more
  3 in total

1.  Autonomously hyperfunctioning cystic nodule harbouring thyroid carcinoma - Case report and literature review.

Authors:  Maria João Lima; Virgínia Soares; Pedro Koch; Artur Silva; António Taveira-Gomes
Journal:  Int J Surg Case Rep       Date:  2018-01-08

2.  Hot and malignant - a case of invasive papillary carcinoma in hyperthyroid patient with hot nodules.

Authors:  Ramesh K Pandey; Eliza Sharma; Sasmit Roy; Saroj Kandel; Sumit Dahal; Muhammad Rajib Hossain; Marie F Schmidt; Zewge Shiferaw-Deribe
Journal:  J Community Hosp Intern Med Perspect       Date:  2018-08-23

3.  Hyperfunctioning thyroid carcinoma: A systematic review.

Authors:  Jun Liu; Ye Wang; Dongzhu Da; Miao Zheng
Journal:  Mol Clin Oncol       Date:  2019-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.